Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

 

C19 Economics site

Three Key Gaps in the Health Economics Research on COVID-19, and Why It Matters

The online platform C19economics was created to support researchers and decision makers by collating the health economic literature published on the COVID-19 pandemic into an easily searchable repository. After reviewing the literature, we found three notable gaps in coverage in terms of geographical focus and topic areas. 

An image of many Covid vaccine bottles.

Can Serology Tests and Seroprevalence Surveys Inform a More Effective Vaccine Roll Out?

Vaccines have become a central instrument of our long-term response to the pandemic. Vaccination campaigns have now started around the world and will confer significant direct protection against infection, severe illness, and death to those inoculated. It may also protect against transmission, though robust evidence is yet to be confirmed.

An image of an African doctor wearing protective mask and gloves using tablet working in clinic.

The New C19economics.org: A Platform to Support the Generation and Use of Health Economics Research to Tackle COVID-19

Since the beginning of the COVID-19 outbreak, the scientific community has worked around the clock to produce evidence to support decision-makers in all aspects of pandemic management. As of April 2021, there are more than 78,000 articles published in peer reviewed journals and pre-prints (as indexed by collabovid.org). Those unprecedented collective research efforts have supported decisionmakers across the world on some of the toughest choices in decades, from closing economies, to procuring vaccines and medical supplies and equipment, and preparing for the uncertain year ahead.

An image of the earth surrounded by a stethoscope, signifying global health

Getting to Convergence: How “Vertical” Health Programs Add Up to A Health System

Historically, donors and multilateral organisations have channelled funding in health through vertical disease programs, typically focussed on one disease area and a set of short- and medium-term objectives. We, and others, have argued that the “convergence” of verticals into a set of essential health benefits with pooled domestic and external funding to support its financing and delivery is the way ahead.

Pages